Gastrointestinal Stent Market

Boston Scientific Corporation (US) and Cook Group (US) are Leading Players in the Gastrointestinal Stent Market

The gastrointestinal stent market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6% during the forecast period of 2021 to 2026. Gastrointestinal (GI) stents are designed for palliative therapy for various diseases causing obstruction in the GI tract. GI stents have a major role in the recanalization of gastrointestinal (GI) tumors and postoperative leak sealing. Other potential applications of GI stents are drug-eluting devices, tissue modeling for benign conditions, and GI tract drainage/anastomosis. Gastrointestinal stent market growth can be attributed to the rising prevalence of GI cancers and other digestive diseases, and changing lifestyles, increasing healthcare expenditure on gastrointestinal procedures, and increasing preference for minimally invasive surgeries.

The prominent players operating in this market include Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Endo-Flex GmbH (Germany), MI-Tech (South Korea), Hobbs Medical Inc. (US), QualiMed (Germany), UK Medical (UK), CITEC (China), Medorah Meditek Pvt. Ltd. (India), Leufen Medical GmbH (Germany), and BCM Corporation (South Korea). These players adopted the strategies of new product launches, partnerships, agreements, and acquisitions to expand their presence in the global gastrointestinal stent market.

To know about the assumptions considered for the study download the pdf brochure

Boston Scientific Corporation

Boston Scientific Corporation dominated the gastrointestinal stent market in 2020. The company focuses on increasing its share in the market by strategically investing in R&D activities. R&D expenditure increased from USD 1,113 million in 2018 to 1,143 million in 2020, with a 2.6% increase from 2018 to 2020. The company is focusing on improving its performance through new capabilities, processes, and advanced innovative technologies, expanding commercial presence globally, and including cost-reduction initiatives. In June 2019, the company presented its plan to extend its product pipeline and strategic investments in the high-growth markets to deliver strong financial performance across the companys MedSurg, Rhythm and Neuro, and Cardiovascular segments. The company has major revenue coming from the US, accounting for 56% of total revenue.

Cook Medical

Cook Medical is the second leading player in the gastrointestinal stent market. The company has its sales and marketing offices all over the globe and provides its products to 135 countries. The company offers a wide range of gastrointestinal stent products for biliary, pancreatic, duodenal, and esophageal applications. The company also focuses on inorganic growth through partnership and collaboration with relevant businesses. For instance, in June 2018, Cook Medical collaborated with Taewoong Medical to expand the distribution network for Taewoong’s stents in the US. This distribution collaboration includes the Niti-S Through the Scope (TTS) Esophageal Stent, the flagship product of Taewoong Medical. Such strategic developments have supported Cook Medical to enhance its market share in the gastrointestinal stent market.

Micro-Tech (Nanjing) Co., Ltd.

Micro-Tech (Nanjing) Co., Ltd. is a third prominent player in the gastrointestinal stent market with immensely diversified gastrointestinal stent offerings. It also has a wide distribution network in Europe, North America, and Oceania. R&D is a significant focus area for the company. The company also collaborates with medical institutes and university laboratories to develop quality products. In order to increase its geographic presence and customer base, Micro-Tech has adopted expansions as one of its major growth strategies. For instance, in June 2018, the company hosted the International Distributors Meeting. This meeting was attended by distributors across the 26 countries for a deep understanding of Micro-Tech product offerings.

Related Reports:

Gastrointestinal Stent Market with COVID-19 Impact by Product (biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents), Material (self-expanding metal stents and plastic stents), Application, End User - Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 5797
RI Published ON
2/11/2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Gastrointestinal Stent Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved